Vaginal Microbiota Management and Impact on Women’s Health
Posted 9th February 2021 by Nicholas Noakes
Speaking at the 7th Microbiome & Probiotics Business Collaboration Forum, Liisa Lehtoranta explored the future possible directions for vaginal microbiome research.
Making the microbiome accessible to millennials
Posted 6th April 2020 by Joshua Sewell
In 2017 Lisa and Alanna MacFarlane started The Gut Stuff to bring gut health science and nutritional information together for the millennial generation. We spoke to Lisa about educating consumers and marketing products in gut health.
Culturing the uncultured: isolating human microbial ‘dark matter’
Posted 11th March 2020 by Joshua Sewell
A large fraction of the microorganisms that constitute the human microbiome have remained uncultured. Some of the uncultured microbes have close relatives that have been cultured. However, there are also whole groups of microbes that don’t have relatives in culture.
How to understand complexity: harness the power of simplicity
Posted 6th March 2020 by Joshua Sewell
One of the most powerful tools in science is the use of simple models that can represent a wide range of other similar systems.
Presentation slides from the 6th Microbiome R&D & Business Collaboration Forum
Posted 9th August 2019 by Jane Williams
Following the Microbiome R&D & Business Collaboration Forum, we have made the following presentation slides available from Finn Terge Hegge, Angela Sessitsch, Evelina Munukka and Jonathan de Jonge.
Microbiome R&D & Business Collaboration Forum presentation slides
Posted 15th July 2019 by Joshua Sewell
Following the Microbiome R&D & Business Collaboration Forum, we have made the following presentation slides from Karoline Faust, Dirk Hadrich, Lesley Hoyles & Jos Seegers available.
Updated List of Prebiotics/Probiotics Companies and Investors
Posted 22nd October 2018 by Jane Williams
The Probiotics/Prebiotics Market
Interest in microbiota, specifically in human health and disease, has encouraged consumers to focus on digestive health, which has seen the probiotics and prebiotics market go from strength-to-strength.
As a result, the global probiotics and prebiotics market was valued at approximately USD 40.09 billion in 2017 and is expected to generate revenue of around USD 65.87 billion by end of 2024, growing at a compound annual growth rate of around 7.35% between 2018 and 2024. [1]
The Emerging Market of the Human Microbiome
Posted 19th January 2018 by Jane Williams
The human microbiome is an area of life sciences that is gaining traction in the venture capital community. According to the Wall Street Journal, venture capital investment in microbiome companies rose 458.5 percent to 114.5 million U.S. dollars during the period from 2011 – 2015.
